Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/19054060

Download in:

View as

General Info

PMID
19054060